Point-Of-Care Testing (Poct) Market In Europe 2026-2030

Point-Of-Care Testing (Poct) Market In Europe 2026-2030

The point-of-care testing (poct) market in europe is forecasted to grow by USD 8247.1 mn during 2025-2030, accelerating at a CAGR of 8.8% during the forecast period. The report on the point-of-care testing (poct) market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by shift toward rapid diagnostics over traditional labs, expansion of telemedicine and remote patient services, growing geriatric population requiring frequent monitoring.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's point-of-care testing (poct) market in europe is segmented as below:

By Type

• OTC testing
• Prescription-based testing

By Application

• Blood glucose testing
• Infectious diseases testing
• Cardiac markers testing
• Pregnancy and fertility testing
• Others

By Platform

• Lateral flow assays
• Immunoassays
• Molecular diagnostics
• Dipsticks
• Others

Geography

• Europe
• Germany
• France
• Italy
• UK

This study identifies the adoption of ai and data analytics in poct as one of the prime reasons driving the point-of-care testing (poct) market in europe growth during the next few years. Also, advancements in microfluidic and lab‑on‑chip technologies and expansion of otc poc tests for self-monitoring health will lead to sizable demand in the market.

The report on the point-of-care testing (poct) market in europe covers the following areas:

• Point-of-care testing (poct) market in europe sizing
• Point-of-care testing (poct) market in europe forecast
• Point-of-care testing (poct) market in europe industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point-of-care testing (poct) market in europe vendors that include A. Menarini Industrie Farma, Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., LifeScan IP Holdings LLC, Nova Biomedical Corp., OraSure Technologies Inc., PHC Holdings Corp., Siemens Healthineers AG, Sinocare Inc., Sysmex Corp., Thermo Fisher Scientific Inc., Trinity Biotech Plc. Also, the point-of-care testing (poct) market in europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more